2018
2019
3.Health Technology Assessment of strategies for Cervical Cancer Screening in India. (PGIMER Chandigarh).
4. Expanding Informed Contraceptive Choice for Indian Women: Health Technology Assessment of Long Acting Reversible Contraceptives (LARC) in India. (NIRRH, Mumbai)
5. Diagnostic efficacy of digital Hemoglobinometer (TrueHb), Hemocue and non-invasive devices for screening patients for Anemia in the field settings. (IIPH, Delhi)
6. Costing of Healthcare services in India (CHSI) Phase -1. (PGI Chandigarh)
7. Device specification & Quality assurance guidelines for Blood Pressure, Blood Glucose & BMI measuring devices. (SCTIMST, Trivandrum,2019)
2020
8.Cost effectiveness analysis of Hypothermia detection devices (BEPMU), Thermospot and Fever Watch) for pre-mature and low birth weight neonates in India. (IIPH Shillong)
9. Health Technology Assessment of Uterine Balloon Tamponade for Management of Postpartum Haemorrhage in India. (NIRRH, Mumbai)
10. Health Technology Assessment of portable automated ABR neonatal hearing screening device (Sohum). (RMRC, Bhubaneshwar)
11.Rapid Health Technology Assessment for incorporating TrueNat as a diagnostic tool for tuberculosis under NTEP in India. (HTAIn Secretariat)
12. Evaluation of Pulse Oximetry as a tool to prevent childhood pneumonia related morbidity and mortality. (SCTIMST, Trivandrum)
13.Health Technology Assessment of Automated Resuscitation Device for Neonatal Resuscitation at point of delivery in Indian healthcare system. (KIHT, Vizag, Vishakhapatnam)
14. Health Technology Assessment of various RT-PCR kits for the diagnosis of Influenza A/H1N1-pdm09 virus in all age patients in India. (NIV, Pune)
15. Health Technology Assessment for screening of Type-2 Diabetes & Hypertension in India. (PGIMER Chandigarh)
2021
16. Health Technology Assessment for screening of Hepatitis B and C at Primary Health Centres (PHC) in Tamil Nadu. (NIRT, Chennai)
17. A comprehensive HTA of Project Lifeline - A portable ECG facility at PHCs of Ahmedabad district of Gujarat. (IIPH, Gandhinagar)
18. Health Technology Assessment of Low Cost Portable Ventilators. (KIHT, Vishakhapatnam)
19. Economic Evaluation of Percutaneous Coronary Intervention(PCI) in comparison to Coronary Artery Bypass Graft (CABG) surgery in Left main with or without Triple Vessel Disease. (HTAIn Secretariat)
20. Economic Evaluation of Percutaneous Coronary Intervention(PCI) in comparison to Optimal Medical Therapy(OMT) for the management of patients with Single-Vessel Disease without left main coronary artery involvement. (HTAIn Secretariat)
21. Economic Evaluation of Coronary Artery Bypass Graft surgery and Percutaneous Coronary Intervention in comparison to Optimal Medical Therapy for the management of patients with Multi-Vessel Disease. (HTAIn Secretariat)
22. EuroQol-EQVT study to develop Indian Value sets for EQ-5D quality of life scores. (PGIMER Chandigarh)
23. Health Technology Assessment of Intravenous Tranexamic Acid use in management of primary post-partum Haemorrhage in India. (NIRRH, Mumbai)
24. Implementation of blood counters for diagnosis of Dengue at primary health care settings in Tamil Nadu state. Implementation of Thrombocytopenia screening at PHC level. (NIRT, Chennai)
25. Health Technology Assessment of TeCHO plus program in Gujarat State. (IIPH, Gandhinagar)
26.Costing of Health Care Services in Tertiary Hospital.
27. Feasibility and effectiveness of Community-based screening for Chronic Kidney diseases. (JIPMER, Puducherry)
28. Health technology assessment report on clinical effectiveness and cost-effectiveness of cholecystectomy compared with conservative management in people presenting with uncomplicated symptomatic gallstones (biliary pain) or Cholecystitis in India. (NIE, Chennai)
29. HTA on available technologies for detection of Diabetic Retinopathy from colour fundus photographs to prevent blindness in India. (SCTIMST, Trivandrum)
30. Estimation of recurrent cost for institutional delivery in different levels of Facilities under JSSK Scheme. (HTAIn Secretariat)
31. Cost Analysis of the Meghalaya Health Benefit Packages. (IIPH Shillong)
32. Life cost Analysis and HTA of COVID-19 diagnostic tools in India. (HTAIn Secretariat)
33. Life cost Analysis and HTA of COVID-19 COBAS and RT-PCR. (HTAIn Secretariat)
2022
34. The Health Technology Assessment of a Paediatric Cardiac Surgery program (HRIDYAM) for Congenital Heart Disease in Kerala. (SCTIMST, Trivandrum)
35. Cost-Effectiveness Analysis of Rapid Diagnostic Kits with Antimicrobial Sensitivity as Point-of-Care Testing in uncomplicated Urinary Tract Infection. (JIPMER, Puducherry)
36. Health Technology Assessment of Telemedicine-Enabled Otoscope (TEO) for Prevention for Ear Diseases. (RMRC, Bhubaneshwar)
37. Health Technology Assessment of Strategies for Oral Cancer Screening in India. (SCI, Lucknow)
38. Clinical Effectiveness and Cost Effectiveness of delivering Inj. Gentamicin in Neonatal Sepsis by ANMs Before Referral. (AIIMS, Jodhpur)
39. Health Technology Assessment on Positron Emission Tomography and Computed Tomography (PET-CT) for Cancer care in India. (KIHT, Vishakhapatnam)
40. Economic evaluation of Trans-Catheter Aortic Valve Replacement (TAVR) compared to Surgical Aortic Valve Replacement (SAVR) among intermediate and high risk patients with Aortic Stenosis (AS) in India. (AIIMS, Rishikesh)
41. Cost -effectiveness of Parenteral Iron Therapy for First- line Management of Iron Deficiency Anemia among Pregnant Women in a Natural Programme Setting in Gujarat. (IIPH, Gandhinagar)
42. Improving adherence through Tuberculosis Medication Regimen using Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD). (IIPH, Gandhinagar)
43. Health Technology Assessment to determine Cost-effectiveness of Rapid Diagnostic Tests (Hemo-Type-Sc, Sickle Scan and Gazelle) in comparison to solubility test followed by HPLC for Sickle Cell Disease/Trait diagnosis in high-risk population. (HTAIn Secretariat, NIRRH Mumbai, PGIMER Chandigarh)
44. Establishing Proton Technology Equipment for Cancer treatment-Is this treatment cost-effective? : A Rapid Health technology Assessment (PGIMER, Chandigarh)
45. Cost-effectiveness analysis & Value-Based Pricing for Anti-Cancer Drugs: Implications for Patients, Industry, Insurer and Regulator (PGIMER, Chandigarh)
46.Assessment of economic burden and Quality of Life among cancer patients in India: National Cancer Database for Costs and Quality of Life (CaDCQoL)
2023
47.To determine cost effectiveness of rapid diagnostic test HPOS (Sicklecert) in comparison to solubility test followed by HPLC for Sickle cell diagnosis
48.Health Technology Assessment on Latent TB Infection Tests Assessing the Costeffectiveness of Latent TB Infection Tests (LTBI) in India.
49. Health Technology Assessment of Telemedicine-Enabled Otoscope (TEO) for Prevention for Ear Diseases. (RMRC, Bhubaneshwar)49. Assessing the cost-effectiveness of the new treatment BPaLM/BPaL for Multi-drug resistant, rifampicin resistant, tuberculosis (MDR-RR-TB) as compared to the currently used oral Bedaquiline containing regimen under the National Tuberculosis Elimination Programme (NTEP)
50.Cost-effectiveness of linking HIV to Family Planning services to prevent unintended pregnancies in people living with HIV women.
51.Cost-effectiveness of rubella vaccination among women in Maharashtra
52.Health Technology Assessment of Rotational Atherectomy for Undilatable Lesions 49. Evaluation and Management of Phase- 2 Drug-Resistant Epilepsy: Health Technology Assessment Perspective
53.Cost-Effectiveness of Neuromodulator for epilepsy/ Deep Brain Stimulation
54.Health technology assessment of Intermittent Auscultation (IA) techniques (Pinard stethoscope, Doppler) for fetal heart rate monitoring against Cardiotocography (continuous/admission) among women without risk factor on their admission to the labour ward in India.
55.Cost effectiveness analysis of inducing therapeutic hypothermia using Phase Changing Material (MiraCradle) to reduce mortality and neurodevelopmental morbidity in moderate and severe Hypoxic-Ischaemic Encephalopathy (HIE)
56. HTA proposal On Cost-Effectiveness of Deep Brain Stimulation for Parkinson's disease in India